Nasser Aghdami
Overview
Explore the profile of Nasser Aghdami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
2160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shahbazi A, Zargar S, Bajouri A, Mohammadi P, Aghdami N
Int J Mol Cell Med
. 2025 Feb;
13(4):387-403.
PMID: 39895913
This study aimed to identify the optimal growth media for culturing human skin melanocytes for clinical applications and to assess their tumorigenic potential both and . Various growth media were...
2.
Azhdari M, Zur Hausen A, Aghdami N, Baghaban-Eslaminejad M
Arch Med Res
. 2025 Jan;
56(3):103142.
PMID: 39837100
Introduction: Endothelial cells (ECs) play a crucial role in many treatments for cardiovascular diseases, such as blood vessel repair, tissue engineering, and drug delivery. The process of differentiating these cells...
3.
Sadri B, Labibzadeh N, Mirmorsali L, Ebrahimi M, Bagherifard A, Arab L, et al.
Cell J
. 2024 Sep;
26(7):446-453.
PMID: 39290122
Objective: Kienböck disease is a rare condition characterized by severe pain and restricted wrist movement. Various palliative methods have been proposed as therapeutic strategies for alleviating symptoms. Mesenchymal stromal cell...
4.
Jalili A, Hajifathali A, Mohammadian M, Sankanian G, Sayahinouri M, Dehghani Ghorbi M, et al.
Adv Pharm Bull
. 2023 Aug;
13(3):469-482.
PMID: 37646062
Hematopoietic stem cell transplantation (HSCT) is a life-saving therapy for various hematologic disorders. Due to the bone marrow suppression and its long recovery period, secondary infections, like cytomegalovirus (CMV), Epstein-Bar...
5.
Shahbazi A, Abedi Valugerdi M, Kazemi S, Samadi Kochaksaraei S, Naseh M, Aghdami N, et al.
Dermatology
. 2023 Aug;
239(6):919-925.
PMID: 37573775
Background: Vitiligo is a common depigmentation skin disease associated with significant psychosocial morbidity and profound effect on the quality of life. The treatment of vitiligo is still a major challenge...
6.
Nabavi S, Karimi S, Arab L, Aghdami N, Joghtaei N, Maroufizadeh S, et al.
Mult Scler Relat Disord
. 2023 Jul;
78:104895.
PMID: 37515913
Multiple sclerosis (MS) is a progressive, demyelinating neurodegenerative disease of the central nervous system. MS is immune-mediated and leads to disability especially in young adults. Even though 18 MS therapy...
7.
Bajouri A, Dayani D, Taj Sharghi A, Karimi S, Niknezhadi M, Moeinabadi Bidgoli K, et al.
Cell J
. 2023 Jul;
25(6):363-371.
PMID: 37434453
Objective: Mesenchymal stromal cells (MSCs) play immunomodulatory role in various autoimmune diseases. Previous pre-clinical and clinical studies have shown that MSCs could be a therapeutic modality for psoriasis. However, the...
8.
Sayahinouri M, Mashayekhi Firouz S, Sadrabadi A, Masoudnia M, Abdolahi M, Jafarzadeh F, et al.
Bioimpacts
. 2023 May;
13(2):159-179.
PMID: 37193075
In late December 2019, a sudden severe respiratory illness of unknown origin was reported in China. In early January 2020, the cause of COVID-19 infection was announced a new coronavirus...
9.
Salehi M, Rezazade-Moayed F, Khalili H, Hemati H, Aghdami N, Dashtkoohi M, et al.
Future Microbiol
. 2023 May;
18:335-342.
PMID: 37140270
To evaluate the safety of megadose meropenem as empirical treatment of nosocomial sepsis. Critically ill patients diagnosed with sepsis received either high-dose (2 g every 8 h) or megadose (4 ...
10.
Kabiri F, Medlej A, Saleh A, Aghdami N, Khani M, Soltani B
Cancer Treat Res Commun
. 2023 Apr;
35:100702.
PMID: 37044020
Background: Hsa-miR-495 (miR-495) has been extensively investigated in cancer initiation and progression. On the other hand, our bioinformatics analysis suggested that miR-495 exerts its effects through targeting of TGFβ signaling...